1. H. Hatanaka, S. Kamano, K. Amano, S. Hojo, K. Sano, S. Egawa, H. Yasukochi, Clinical experience of boron-neutron capture therapy for gliomas-a comparison with conventional chemoimmuno-radiotherapy, in: Boron-Neutron Capture Therapy for Tumors, H. Hatanaka, ed., Nishimura and Co., Niigata, Japan (1986).
2. D.D. Joel, D.N. Slatkin, R.G. Fairchild, P.L. Micca, and M.M. Nawrocky, Pharmacokinetics and tissue distribution of the sulfhydryl boranes (monomer and dimer) in glioma-bearing rats, Strahlentherap. Onkol. 165:167 (1989).
3. D.D. Joel, V. Benary, R.M. Brugger, and J.A. Coderre, Some aspects of BNCT research at the Brookhaven National Laboratory, in: “Proceedings of the International Workshop Towards Clinical Trials of Glioma with BNCT”, D. Gabel and R. Moss, eds., Plenum Press, New York.(In Press)
4. G.R. Wellum, E.I. Tolpin, A.H. Soloway, and A. Kaczmarczyk, Synthesis of µ-disulfido-bis (undecahydrocloso-dodecaborate) (4-) and of a derived free radical, Inorg. Chem. 16:2120 (1977).
5. M.E. Anderson, F. Powrie, R.N. Puri, and A. Meister, Glutathione monoethyl ester: preparation, uptake by tissue and conversion to glutathione, Arch. Biochem, Biophys. 239:538–548 (1985).